bioAffinity Technologies wins Hong Kong patent for CyPath Lung
bioAffinity Technologies said Hong Kong granted a patent for its CyPath Lung technology, strengthening its intellectual property protection in Asia.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.